Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
---|
06/11/1997 | EP0777673A2 Alpha-d-pentofuranoside derivatives, process for preparing the same and their use |
06/11/1997 | EP0777672A1 Amino acid chelates having improved palatability |
06/11/1997 | EP0777671A1 Spiro-azabicyclic compounds useful in therapy |
06/11/1997 | EP0777670A1 Substituted camptothecin derivatives and process for their preparation |
06/11/1997 | EP0777669A1 4-(2-amino-6-(cyclopropylamino)-9h-purin-9-yl)-2-cyclopentene-1-methanol succinate as antiviral agent |
06/11/1997 | EP0777668A1 Novel n-substituted naphthofused lactams |
06/11/1997 | EP0777667A1 Cyclic benzazepine urea derivatives with aggregation-inhibiting effect |
06/11/1997 | EP0777666A1 Novel substituted piperidines useful for the treatment of allergic diseases |
06/11/1997 | EP0777665A1 Hemoregulatory compounds |
06/11/1997 | EP0777663A1 Use of substituted 6-amino-4h-pyrans |
06/11/1997 | EP0777661A1 Natriuretic and anti-hypertensive compounds |
06/11/1997 | EP0777660A1 Novel alkylamino derivatives as sigma 2 selective ligands |
06/11/1997 | EP0777659A1 Morpholine derivatives and their use as therapeutic agents |
06/11/1997 | EP0777657A1 Bicyclic compounds |
06/11/1997 | EP0777653A1 Dihygropyridine derivatives as bradykinin antagonists |
06/11/1997 | EP0777652A1 Neuroprotective 3-(piperidinyl-1)-chroman-4,7-diol and 1-(4-hydrophenyl)-2-(piperidinyl-1)-alkanol derivatives |
06/11/1997 | EP0777650A1 Biphenylamide derivatives as 5ht 1d? antagonists |
06/11/1997 | EP0777649A1 N- 2-(pyrrolidinyl-1)-1-phenylethyl]acetamides as kappa receptor antagonists |
06/11/1997 | EP0777646A1 Metalloproteinase inhibitors |
06/11/1997 | EP0777644A1 D-b-lysylmethanediamine derivatives with bacteria, aids virus and tumor cell growth inhibiting activity and preparation thereof |
06/11/1997 | EP0777641A1 Anti-inflammatory preparation |
06/11/1997 | EP0777499A1 Live vaccine for the treatment of tumour diseases |
06/11/1997 | EP0777498A1 Conjugates made of metal complexes and oligonucleotides |
06/11/1997 | EP0777493A1 Calcitonin gene related peptide receptor |
06/11/1997 | EP0777491A1 Use of tasteless, hydrolysed collagen and agent containing the same |
06/11/1997 | EP0777487A1 Treatment of disease and conditions associated with macrophage infiltration in particular stroke and myocardial infarction |
06/11/1997 | EP0777485A1 2',5' phosphorothioate/phosphodiester oligoadenylates and antiviral uses thereof |
06/11/1997 | EP0777484A1 Intravenous alendronate formulations |
06/11/1997 | EP0777483A1 Methods and means for drug administration |
06/11/1997 | EP0777482A1 Combined preparation for the therapy of immune diseases |
06/11/1997 | EP0777481A1 Use of n-substituted phenothiazines |
06/11/1997 | EP0777480A1 Optic nerve health |
06/11/1997 | EP0777479A1 Dioxolenylmethyl carbamates promoieties for amine drugs |
06/11/1997 | EP0777478A1 Inhibitors of rotamase enzyme activity |
06/11/1997 | EP0777477A1 Improved pharmaceutical formulations containing ibuprofen and codeine |
06/11/1997 | EP0777476A1 Methods of inhibiting endometrial cancer |
06/11/1997 | EP0777475A1 Inhibitors of farnesyl-protein transferase |
06/11/1997 | EP0777474A1 Methods for the treatment of inflammatory joint disease |
06/11/1997 | EP0777473A1 Compositions and methods for the control of smoking |
06/11/1997 | EP0777472A2 Methods for identifying and treating resistant tumors |
06/11/1997 | EP0777471A1 Inhibition of leukotriene biosynthesis with urea derivatives |
06/11/1997 | EP0777470A1 Use of paracellular absorption enhancers such as glucose for enhancing the absorption of histamine h2-antagonists |
06/11/1997 | EP0777469A1 Use of insulin sensitisers for treating renal diseases |
06/11/1997 | EP0777463A2 Gelling compositions comprising optically enriched gellants |
06/11/1997 | EP0777458A1 Control of hair growth |
06/11/1997 | EP0777457A1 Use of glyceryl triacetate for treating onychomycoses |
06/11/1997 | EP0777415A1 Anandamide analogue compositions and method of treating intraocular hypertention using same |
06/11/1997 | EP0777414A1 Sprayable film forming system releasing active substances for use on plants |
06/11/1997 | EP0746320A4 Hiv protease inhibitors and intermediates |
06/11/1997 | EP0723442A4 Lactone compounds for treating patients with precancerous lesions |
06/11/1997 | EP0716615A4 Low flux transdermal potent drug delivery system |
06/11/1997 | EP0712411B1 Antiparasitic agents |
06/11/1997 | EP0703913B1 Imidazoles as lipoxygenase inhibitors |
06/11/1997 | EP0700395B1 Indole derivatives as steroid 5-alpha-reductase inhibitors |
06/11/1997 | EP0695128B1 Nutrient fats having improved digestibility |
06/11/1997 | EP0662964B1 Heterocyclic amines having calmodulin antagonist properties |
06/11/1997 | EP0656786A4 Health supplements containing phyto-oestrogens, analogues or metabolites thereof. |
06/11/1997 | EP0654991B1 Inhalation powder containing antistatic agent |
06/11/1997 | EP0633763B1 Cosmetical or pharmaceutical compositions comprising deacylated glycerophospholipids for topical use |
06/11/1997 | EP0600085B1 Inhibitor for blood vessel hypertrophy |
06/11/1997 | EP0557305B1 (2-thienyl) alkylamine derivatives having neuroprotective properties |
06/11/1997 | CN1151758A Novel growth of differentiation factor of the TGF- 'beta' family |
06/11/1997 | CN1151746A Novel erythromycin derivatives, method for their preparation and their use as drugs |
06/11/1997 | CN1151741A Method for preparing 4-acetoxy-2 'alpha'-benzoyloxy-5 'beta', 20-epoxy-1,7 'beta', 10 'beta'-trihydroxy-9-oxo-tax-11-en-13 'alpha'-yl(2R, 3S)-3-tert-butoxycarbonylamino-2-hydroxy-3-phenylpropion |
06/11/1997 | CN1151740A 7-ether-taxol analogs, antineoplastic use and pharmaceutical compsns. containing them |
06/11/1997 | CN1151736A Di-oxadiazole derivatives as antihyperglycemic agents |
06/11/1997 | CN1151735A Benzocycloalkylazolethione derivatives |
06/11/1997 | CN1151732A Tri-substituted phenyl derivates useful as PDE IV inhibitors |
06/11/1997 | CN1151729A Aryl and heteroaryl alkoxynaphtalene derivatives |
06/11/1997 | CN1151702A Low viscosity chelating polymers |
06/11/1997 | CN1151701A Cascade-polymer complexes and method of producing the same |
06/11/1997 | CN1151698A Pharmaceutical compsn. for treating peripheral circulation disorder |
06/11/1997 | CN1151697A Anti-hiv triple combination |
06/11/1997 | CN1151696A 抗菌剂 Antibacterial agents |
06/11/1997 | CN1151695A Benzamide-containing pharmaceutical compsns. |
06/11/1997 | CN1151693A Pharmaceutical preparation with a hydrophobic active substance and an effervescent system, and process for preparing said prparation |
06/11/1997 | CN1151405A Propiophenone derivative and processes for preparing the same |
06/11/1997 | CN1151403A Crystals of piperidine derivatives, intermediates for production of same, and process for producing the same |
06/11/1997 | CN1151401A Use of intermediates for production of aromatic aminoalcohol derivatives having anti-diabetic and anti-obesity properties |
06/11/1997 | CN1151400A Novel sulfonylaminopyrimidines |
06/11/1997 | CN1151399A Novel hydroxylpyridinones |
06/11/1997 | CN1151288A Nutrient for prevention and treatment of fatty liver caused by drinking wine and fat and its mfg. method |
06/11/1997 | CN1151287A Animal medicinal composition |
06/11/1997 | CN1151286A 双利合剂 Lee double agent |
06/11/1997 | CN1151285A Diclofenac ointment and its prepn. method |
06/11/1997 | CN1035112C Improved process for useful diazinylpiperides derivatives |
06/10/1997 | US5637771 Compound useful for lowering cholesterol |
06/10/1997 | US5637768 Process for making (2S,5S)-5-fluoromethylornithine |
06/10/1997 | US5637742 Wound healing agents, skin disorders, cosmetics |
06/10/1997 | US5637723 Esterification of baccatine; deblocking |
06/10/1997 | US5637721 Process for the preparation of cephem prodrug esters |
06/10/1997 | US5637712 Process of preparing isoquinoline compounds |
06/10/1997 | US5637711 Chemical intermediate; 1-epoxidemethyl substituted piperazine ring |
06/10/1997 | US5637710 Intermediate compounds in the synthesis of heteroarylpiperidines and piperazines |
06/10/1997 | US5637707 2-substituted tertiary carbinol derivatives of 1, 5-iminosugars |
06/10/1997 | US5637706 Actinic radiation stabilizers |
06/10/1997 | US5637703 Derivatives of genistein |
06/10/1997 | US5637698 Fused multiple ring lactams |
06/10/1997 | US5637697 1,5-benzodiazepine derivatives and their use in medicine |
06/10/1997 | US5637691 Steroid derivatives, pharmaceutical compositions containing them, and their use as antibiotics or disinfectants |